open access
The use of remote monitoring of patients with cardiac implantable electronic devices in Poland
Affiliations- 3rd Department of Cardiology, School of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
- 1st Chair and Department of Cardiology, Medical University of Warsaw, Warszawa, Poland
- Biotronik Polska, Poznań, Poland
open access
Abstract
Abstract
Supp./Additional Files (1)
About this articleTitle
The use of remote monitoring of patients with cardiac implantable electronic devices in Poland
Journal
Kardiologia Polska (Polish Heart Journal)
Issue
Article type
Short communication
Pages
479-481
Published online
2022-02-16
Page views
313
Article views/downloads
116
DOI
10.33963/KP.a2022.0050
Pubmed
Bibliographic record
Kardiol Pol 2022;80(4):479-481.
Authors
Mateusz Tajstra
Maciej Dyrbuś
Marcin Grabowski
Jakub K Rokicki
Marcin Nowak
Mariusz Gąsior
References (12)- Kurek A, Tajstra M, Gadula-Gacek E, et al. Impact of Remote Monitoring on Long-Term Prognosis in Heart Failure Patients in a Real-World Cohort: Results From All-Comers COMMIT-HF Trial. J Cardiovasc Electrophysiol. 2017; 28(4): 425–431.
- Michowitz Y, Kronborg MB, Glikson M, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Europace. 2022; 24(1): 71–164.
- Hindricks G, Taborsky M, Glikson M, et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Lancet. 2014; 384(9943): 583–590.
- Hindricks G, Varma N, Kacet S, et al. Daily remote monitoring of implantable cardioverter-defibrillators: insights from the pooled patient-level data from three randomized controlled trials (IN-TIME, ECOST, TRUST). Eur Heart J. 2017; 38(22): 1749–1755.
- Tajstra M, Sokal A, Gadula-Gacek E, et al. Remote Supervision to Decrease Hospitalization Rate (RESULT) study in patients with implanted cardioverter-defibrillator. Europace. 2020; 22(5): 769–776.
- Wita M, Orszulak M, Szydło K, et al. The usefulness of telemedicine devices in patients with severe heart failure with an implanted cardiac resynchronization therapy system during two years of observation. Kardiol Pol. 2022; 80(1): 41–48.
- Mairesse GH, Braunschweig F, Klersy K, et al. Implementation and reimbursement of remote monitoring for cardiac implantable electronic devices in Europe: a survey from the health economics committee of the European Heart Rhythm Association. Europace. 2015; 17(5): 814–818.
- Papavasileiou LP, Forleo GB, Panattoni G, et al. Work burden with remote monitoring of implantable cardioverter defibrillator: is it time for reimbursement policies? J Cardiovasc Med (Hagerstown). 2013; 14(2): 114–119.
- O'Shea CJ, Middeldorp ME, Hendriks JM, et al. Remote Monitoring Alert Burden: An Analysis of Transmission in >26,000 Patients. JACC Clin Electrophysiol. 2021; 7(2): 226–234.
- Recommendation of the Agency for Health Technology Assessment and Tariff System (AOTMiT) no 101/2018 from 25 October 2018 entitled “Telemetric monitoring of patients with an implanted cardioversion-defibrillation system (ICD) or cardiac resynchronization therapy with defibrillation function (CRT-D)” as a guaranteed outpatient specialised care service. Available online: https: //bipold.aotm.gov.pl/assets/files/zlecenia_mz/2018/173/REK/RP_101_2018_nadzor_telemetryczny.pdf. (Access: December 14, 2021).
- Buchta P, Tajstra M, Kurek A, et al. The impact of remote monitoring of implanted cardioverter-defibrillator (ICD) and cardiac resynchronisation therapy device (CRT-D) patients on healthcare costs in the Silesian population: three-year follow-up. Kardiol Pol. 2017; 75(6): 573–580.
- Health Quality Ontario. Remote Monitoring of Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy and Permanent Pacemakers: A Health Technology Assessment. Ont Health Technol Assess Ser. 2018; 18(7): 1–199.
